Verastem (VSTM) Receivables (2018 - 2026)

Verastem's (VSTM) quarterly Receivables came in at $10.2 million in Q1 2026, up 15.26% quarter-over-quarter from $8.8 million in Q4 2025.

Verastem (VSTM) Receivables (2018 - 2026) Analysis & Trends

Verastem's Receivables history runs 9 years deep, the most recent figure standing at $10.2 million for Q1 2026.

  • On a quarterly basis, Receivables changed N/A year-over-year to $10.2 million in Q1 2026; TTM through Mar 2026 was $10.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $8.8 million, changed N/A from the prior year.
  • Receivables rose to $10.2 million in Q1 2026 per VSTM's latest filing, from $8.8 million in the prior quarter.
  • Across five years, Receivables topped out at $10.2 million in Q1 2026 and bottomed at $31000.0 in Q4 2022.
  • The 5-year median for Receivables is $200000.0 (2022), against an average of $3.2 million.
  • Across the five-year window, Receivables plunged 97.66% in 2023 and jumped 16029.03% in 2024, its largest moves.
  • Year by year, Receivables stood at $31000.0 in 2022, then jumped by 35.48% to $42000.0 in 2023, then soared by 23709.52% to $10.0 million in 2024, then slipped by 11.87% to $8.8 million in 2025, then grew by 15.26% to $10.2 million in 2026.
  • Per Business Quant, the three latest VSTM Receivables figures stand at $10.2 million (Q1 2026), $8.8 million (Q4 2025), and $6.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 4.97 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 938.02 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.13 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 2.00 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.73 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.93 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Verastem 166.09 Mn -31.73 Mn 15.90 Mn 10.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10.16 Mn
Dec 31, 2025 8.81 Mn
Sep 30, 2025 6.72 Mn
Jun 30, 2025 2.08 Mn
Jun 30, 2024 10.00 Mn
Dec 31, 2023 42,000.00
Sep 30, 2023 42,000.00
Jun 30, 2023 62,000.00
Mar 31, 2023 62,000.00
Dec 31, 2022 31,000.00
Sep 30, 2022 125,000.00
Jun 30, 2022 200,000.00
Mar 31, 2022 2.64 Mn
Dec 31, 2021 170,000.00
Sep 30, 2021 130,000.00
Jun 30, 2021 476,000.00
Mar 31, 2021 1.13 Mn
Dec 31, 2020 239,000.00
Sep 30, 2020 5.69 Mn
Jun 30, 2020 1.50 Mn